Metabolism resistant fenfluramine analogs and methods of using the same
US11673852B2 · kind B2 · utility
2Cited by
60References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2022 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Apr 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Metabolism-resistant fenfluramine analogs are provided. The subject fenfluramine analogs find use in the treatment of a variety of diseases. For example, methods of treating epilepsy by administering a fenfluramine analog to a subject in need thereof are provided. Also provided are methods of suppressing appetite in a subject in need thereof. Pharmaceutical compositions for use in practicing the subject methods are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.